stockportfolio.pro
Sarepta Therapeutics, Inc. Total Debt 2009–2025
Sarepta Therapeutics, Inc. (SRPT) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $828.97M | -27.1% |
| FY 2024 | $1.14B | -8.1% |
| FY 2023 | $1.24B | -19.8% |
| FY 2022 | $1.54B | +174.0% |
| FY 2021 | $563.67M | — |
| FY 2020 | $0 | — |
| FY 2019 | $0 | -100.0% |
| FY 2018 | $420.55M | -2.4% |
| FY 2017 | $431.05M | +2339.7% |
| FY 2016 | $17.67M | -34.2% |
| FY 2015 | $26.84M | +278.1% |
| FY 2014 | $7.10M | +325.5% |
| FY 2013 | $1.67M | -5.1% |
| FY 2012 | $1.76M | +0.0% |
| FY 2011 | $1.76M | -4.6% |
| FY 2010 | $1.84M | — |
| FY 2009 | $0 | — |
Source: Sarepta Therapeutics, Inc. SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for Sarepta Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeSarepta Therapeutics, Inc. — frequently asked questions
What is Sarepta Therapeutics, Inc.'s total debt (short- plus long-term borrowings)?
Sarepta Therapeutics, Inc. (SRPT) reported total debt (short- plus long-term borrowings) of $828.97M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Sarepta Therapeutics, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.